Genetics of Diabetic Retinopathy

References

• Klein BE. Overview of epidemiologicstudies of diabetic retinopathy. Ophthalmic Epidemiol 2007;14:179–183
   PubMed Web of Science ®Google Scholar
• Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35(3):556–564
   PubMed Web of Science ®Google Scholar
• IDF. Diabetes Atlas, 5th ed. Brussels: International Diabetes Federation, 2011. Available from: http://www.idf.org/diabetesatlas
   Google Scholar
• Liew G, Klein R, Wong TY. The role of genetics in susceptibility to diabetic retinopathy. Int Ophthalmol Clin 2009;49(2):35–52
   PubMedGoogle Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabeticretinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102(4):520–526
   PubMedGoogle Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabeticretinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102(4):527–532
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14):977–986
   PubMed Web of Science ®Google Scholar
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33): UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352(9131):837–853
   Google Scholar
• Matthews DR, Stratton IM, Aldington SJ, et al. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol 2004;122(11):1631–1640
   PubMedGoogle Scholar
• Patel A, MacMahon S, Chalmers J, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial. Lancet 2007;370(9590):829–840
   PubMed Web of Science ®Google Scholar
• Beulens JW, Patel A, Vingerling JR, et al.; AdRem project team; ADVANCE management committee. Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: A randomised controlled trial. Diabetologia 2009;52(10):2027–2036
   PubMed Web of Science ®Google Scholar
• Keenan HA, Costacou T, Sun JK, et al. Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: The 50-year medalist study. Diabetes Care 2007;30(8):1995–1997
   PubMed Web of Science ®Google Scholar
• Sun JK, Keenan HA, Cavallerano JD, et al. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: The joslin 50-year medalist study. Diabetes Care 2011;34(4):968–974
   PubMedGoogle Scholar
• Wong TY, Klein R, Islam FM, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol 2006;141(3):446–455
   PubMed Web of Science ®Google Scholar
• Klein R, Sharrett AR, Klein BE, et al. The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: The atherosclerosis risk in communities study. Ophthalmology 2002;109(7):1225–1234
   PubMed Web of Science ®Google Scholar
• Haffner SM, Fong D, Stern MP, et al. Diabetic retinopathy in Mexican Americans and non-Hispanic whites. Diabetes 1988;37(7):878–884
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Group. Clustering of long-term complications in families with diabetes in the Diabetes Control and Complications Trial. Diabetes 1997; 46:1829–1839
   PubMedGoogle Scholar
• Rema M, Saravanan G, Deepa R, Mohan V. Familial clustering of diabetic retinopathy in South Indian type 2 diabetic patients. Diabet Med 2002;19:910–916
   PubMed Web of Science ®Google Scholar
• Hallman DM, Huber JC Jr, Gonzalez VH, et al. Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care 2005;28:1163–1168
   PubMed Web of Science ®Google Scholar
• Zhang X, Gao Y, Zhou Z, et al. Familial clustering of diabetic retinopathy in Chongqing, China, type 2 diabetic patients. Eur J Ophthalmol 2010;20:911–918
   PubMed Web of Science ®Google Scholar
• Arar NH, Freedman BI, Adler SG, et al. Family Investigation of Nephropathy and Diabetes Research Group. Heritability of the severity of diabetic retinopathy: The FIND-Eye study. Invest Ophthalmol Vis Sci 2008;49:3839–3845
   PubMed Web of Science ®Google Scholar
• Hietala K, Forsblom C, Summanen P, Groop PH. Heritability of proliferative diabetic retinopathy. Diabetes 2008;57:2176–2180
   PubMed Web of Science ®Google Scholar
• Schwartz S, Brantley M Jr, Flynn H Jr. Genetics and diabetic retinopathy. Current Diabetes Reviews 2012;9:86–92
   Google Scholar
• Klein R, Klein BE, Magli YL, et al. An alternative method of grading diabetic retinopathy. Ophthalmology 1986;93(9):1183–1187
   PubMed Web of Science ®Google Scholar
• Wilkinson CP, Ferris FL III, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110(9):1677–1682
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE. The relation of systemic hypertension to changes in the retinal vasculature: The Beaver Dam Eye Study. Trans Am Ophthalmol Soc 1997;95:329–348
   PubMedGoogle Scholar
• Cugati S, Cikamatana L, Wang JJ, Kifley A, Liew G, Mitchell P. Five-year incidence and progression of vascular retinopathy in persons without diabetes: The Blue Mountains Eye Study. Eye. 2005. Available from: http://casereports.bmj.com/content/2012/bcr-2012-007128.long
   Google Scholar
• Uhlmann K, Kovacs P, Boettcher Y, et al. Genetics of diabetic retinopathy. Exp Clin Endocrinol Diabetes 2006;114:275–294
   PubMed Web of Science ®Google Scholar
• Kwon JM, Goate AM. The candidate gene approach. Alcohol Res Health 2000; 24(3):164–168
   PubMedGoogle Scholar
• Zhu M, Zhao S. Candidate gene identification approach: Progress and challenges. Int J Biol Sci 2007;3(7):420–427
   PubMed Web of Science ®Google Scholar
• Manolio TA, Guttmacher, Alan E, et al. Genome wide association studies and assessment of the risk of disease. N Engl J Med 2010;363(2):166–176
   PubMed Web of Science ®Google Scholar
• Imperatore G, Hanson RL, Pettitt DJ, et al. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes 1998;47:821–830
   PubMed Web of Science ®Google Scholar
• Looker HC, Nelson RG, Chew E, et al. Genome-wide linkage analyses to identify loci for diabetic retinopathy. Diabetes 2007;56:1160–1166
   PubMed Web of Science ®Google Scholar
• Hallman DM, Boerwinkle E, Gonzalez VH, et al. A genome-wide linkage scan for diabetic retinopathy susceptibility genes in Mexican Americans with type 2 diabetes from Starr County, Texas. Diabetes 2007;56:1167–1173
   PubMed Web of Science ®Google Scholar
• Duh E, Aiello LP. Vascular endothelial growth factor and diabetes: The agonist versus antagonist paradox. Diabetes 1999;48:1899–1906
   PubMed Web of Science ®Google Scholar
• Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994;118:445–450
   PubMed Web of Science ®Google Scholar
• Al-Kateb H, Mirea L, Xie X, et al. DCCT/EDIC Research Group. Multiple variants in vascular endothelial growth factor (VEGF-A) are risk factors for time to severe retinopathy in type 1 diabetes: The DCCT/EDIC genetics study. Diabetes 2007;56:2161–2168
   PubMed Web of Science ®Google Scholar
• Awata T, Inoue K, Kurihara S, et al. A common polymorphism in the 5’-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002;51:1635–1639
   PubMed Web of Science ®Google Scholar
• Suganthalakshmi B, Anand R, Kim R, et al. Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol Vis 2006;12:336–341
   PubMed Web of Science ®Google Scholar
• Szaflik JP, Wysocki T, Kowalski M, et al. An association between vascular endothelial growth factor gene promoter polymorphisms and diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2008;246:39-43
   PubMed Web of Science ®Google Scholar
• Awata T, Kurihara S, Takata N, et al. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Biochem Biophys Res Commun 2005;333:679–685
   PubMed Web of Science ®Google Scholar
• Buraczynska M, Ksiazek P, Baranowicz-Gaszczyk I, Jozwiak L. Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients. Nephrol Dial Transplant 2007;22:827–832
   PubMed Web of Science ®Google Scholar
• Chun MY, Hwang HS, Cho HY, et al. Association of vascular endothelial growth factor polymorphisms with nonproliferative and proliferative diabetic retinopathy. J Clin Endocrinol Metab 2010;95:3547–3551
   PubMed Web of Science ®Google Scholar
• Nakamura S, Iwasaki N, Funatsu H, et al. Impact of variants in the VEGF gene on progression of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2009;247:21–26
   PubMed Web of Science ®Google Scholar
• Feghhi M, Nikzamir A, Esteghamati A, et al. Relationship of vascular endothelial growth factor (VEGF) +405 G/C polymorphism and proliferative retinopathy in patients with type 2 diabetes. Transl Res 2011;158:85–91
   PubMedGoogle Scholar
• Ray D, Mishra M, Ralph S, et al. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 2004;53:861–864
   PubMed Web of Science ®Google Scholar
• Churchill AJ, Carter JG, Ramsden C, et al. VEGF polymorphisms are associated with severity of diabetic retinopathy. Invest Ophthalmol Vis Sci 2008;49:3611–3616
   PubMedGoogle Scholar
• Uthra S, Raman R, Mukesh BN, et al. Association of VEGF gene polymorphisms with diabetic retinopathy in a south Indian cohort. Ophthalmic Genet 2008;29:11–15
   PubMed Web of Science ®Google Scholar
• Larkins RG, Dunlop ME. The link between hyperglycaemia and diabetic nephropathy. Diabetologia 1992;35:499–504
   PubMed Web of Science ®Google Scholar
• Hohman TC, Nishimura C, RobisonWG Jr. Aldose reductase and polyol in cultured pericytes of human retinal capillaries. Exp Eye Res 1989;48:55–60
   PubMed Web of Science ®Google Scholar
• Engerman RL, Kern TS. Experimental galactosemia produces diabetic-like retinopathy. Diabetes 1984;33(1):97–100
   PubMed Web of Science ®Google Scholar
• Lee SC, Wang Y, Ko GT, et al. Association of retinopathy with a microsatellite at 5′ end of the aldose reductase gene in Chinese patients with late onset Type 2 diabetes. Ophthalmic Genet 2001;22(2):63–67
   PubMedGoogle Scholar
• Ko BC, Lam KS, Wat NM, Chung SS. An (A–C)n dinucleotide repeat polymorphic marker at the 5′ end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients. Diabetes 1995;44:727–732
   PubMed Web of Science ®Google Scholar
• Olmos P, Futers S, Acosta AM, et al. (AC)23 [Z-2] polymorphism of the aldose reductase gene and fast progression of retinopathy in Chilean type 2 diabetics. Diabetes Res Clin Pract 2000;47:169–176
   PubMed Web of Science ®Google Scholar
• Fujisawa T, Ikegami H, Kawaguchi Y, et al. Length rather than a specific allele of dinucleotide repeat in the 5’ upstream region of the aldose reductase gene is associated with diabetic retinopathy. Diabet Med 1999;16:1044–1047
   PubMed Web of Science ®Google Scholar
• Ichikawa F, Yamada K, Ishiyama-Shigemoto S, et al. Association of an (A-C)n dinucleotide repeat polymorphic marker at the 5’-region of the aldose reductase gene with retinopathy but not with nephropathy or neuropathy in Japanese patients with type 2 diabetes mellitus. Diabet Med 1999;16:744–748
   PubMed Web of Science ®Google Scholar
• Kumaramanickavel G, Sripriya S, Ramprasad VL, et al. Z-2 aldose reductase allele and diabetic retinopathy in India. Ophthalmic Genet 2003;24:41–48
   PubMedGoogle Scholar
• Ikegishi Y, Tawata M, Aida K, Onaya T. Z-4 allele upstream of the aldose reductase gene is associated with proliferative retinopathy in Japanese patients with NIDDM, and elevated luciferase gene transcription in vitro. Life Sci 1999;65:2061–2070
   PubMed Web of Science ®Google Scholar
• Uthra S, Raman R, Mukesh BN, et al. Diabetic retinopathy: Validation study of ALR2, RAGE, iNOS and TNFB gene variants in a south Indian cohort. Ophthalmic Genet 2010;31:244–251
   PubMed Web of Science ®Google Scholar
• Richeti F, Noronha RM, Waetge RT, et al. Evaluation of AC(n) and C(-106)T polymorphisms of the aldose reductase gene in Brazilian patients with DM1 and susceptibility to diabetic retinopathy. Mol Vis 2007;13:740–745
   PubMed Web of Science ®Google Scholar
• Park HK, Ahn CW, Lee GT, et al. (AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus. Diabetes Res Clin Pract 2002;55:151–157
   PubMed Web of Science ®Google Scholar
• Li Q, Xie P, Huang J, et al. Polymorphisms and functions of the aldose reductase gene 5’ regulatory region in Chinese patients with type 2 diabetes mellitus. Chin Med J (Engl) 2002;115:209–213
   PubMed Web of Science ®Google Scholar
• Santos KG, Tschiedel B, Schneider J, et al. Diabetic retinopathy in Euro-Brazilian type 2 diabetic patients: Relationship with polymorphisms in the aldose reductase, the plasminogen activator inhibitor-1 and the methylenetetrahydrofolate reductase genes. Diabetes Res Clin Pract 2003;61:133–136
   PubMed Web of Science ®Google Scholar
• Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: A systematic review. JAMA 2007;298(8):902–916
   PubMed Web of Science ®Google Scholar
• Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation 2006;114(6):597–605
   PubMed Web of Science ®Google Scholar
• Lindholm E, Bakhtadze E, Cilio C, et al. Association between LTA, TNF and AGER polymorphisms and late diabetic complications. PLoS One 2008;3:e2546
   PubMed Web of Science ®Google Scholar
• Ramprasad S, Radha V, Mathias RA, et al. Rage gene promoter polymorphisms and diabetic retinopathy in a clinic-based population from South India. Eye 2007;21:395–401
   PubMed Web of Science ®Google Scholar
• Kumaramanickavel G, Ramprasad VL, Sripriya S, et al. Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients. J Diabetes Complications 2002;16:391–394
   PubMedGoogle Scholar
• Hudson BI, Stickland MH, Futers TS, Grant PJ. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 2001;50:1505–1511
   PubMed Web of Science ®Google Scholar
• JiXiong X, BiLin X, MingGong Y, ShuQin L. -429 T/C and -374 T/A polymorphisms of RAGE gene promoter are not associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Diabetes Care 2003;26:2696–2697
   PubMedGoogle Scholar
• Globocnik Petrovic M, Steblovnik K, Peterlin B, Petrovic D. The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene are not risk factors for diabetic retinopathy in Caucasians with type 2 diabetes. Klin Monbl Augenheilkd 2003;220:873–876
   PubMedGoogle Scholar
• Kang P, Tian C, Jia C. Association of RAGE gene polymorphisms with type 2 diabetes mellitus, diabetic retinopathy and diabetic nephropathy. Gene 2012;500:1–9
   PubMed Web of Science ®Google Scholar
• Tong Z, Yang Z, Patel S, et al. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci USA. 2008;105(19):6998–7003
   PubMed Web of Science ®Google Scholar
• Deinum J, Derkx FH, Danser AH, Schalekamp MA. Identification and quantification of renin and prorenin in the bovine eye. Endocrinology 1990;126:1673–1682
   PubMed Web of Science ®Google Scholar
• Wagner J, Jan Danser AH, Derkx FH, et al. Demonstration of reninmRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: Evidence for an intraocular renin-angiotensin system. Br J Ophthalmol 1996;80:159–163
   PubMed Web of Science ®Google Scholar
• Le Noble FA, Hekking JW, Van Straaten HW, et al. Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur J Pharmacol 1991;195:305–306
   PubMed Web of Science ®Google Scholar
• Thomas GN, Critchley JA, Tomlinson B, et al. Renin-angiotensin system gene polymorphisms and retinopathy in Chinese patients with type 2 diabetes. Diabetes Care 2003;26:1643–1644
   PubMed Web of Science ®Google Scholar
• Gutierrez C, Vendrell J, Pastor R, et al. Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin dependent diabetes mellitus: Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population. Metabolism 1997;46:976–980
   PubMedGoogle Scholar
• Cruickshanks KJ, Vadheim CM, Moss SE, et al. Genetic marker associations with proliferative retinopathy in persons diagnosed with diabetes before 30 yr of age. Diabetes 1992;41:879–885
   PubMedGoogle Scholar
• Wong TY, Cruickshanks KJ, Klein R, et al. HLA-DR3 and DR4 and their relation to the incidence and progression of diabetic retinopathy. Ophthalmology 2002;109:275–281
   PubMedGoogle Scholar
• Sobrin L, Green T, Sim X, et al. Family Investigation of Nephropathy and Diabetes-Eye Research Group, Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: The Candidate Gene Association Resource (CARe). Invest Ophthalmol Vis Sci 2011;52:7593–7602
   PubMedGoogle Scholar
• Warpeha KM, Xu W, Liu L, et al. Genotyping and functional analysis of a polymorphic (CCTTT)(n) repeat of NOS2A in diabetic retinopathy. FASEB J 1999;13:1825–1832
   PubMed Web of Science ®Google Scholar
• Matsubara Y, Murata M, Maruyama T, et al. Association between diabetic retinopathy and genetic variations in alpha2beta1 integrin, a platelet receptor for collagen. Blood 2000;95:1560–1564
   PubMed Web of Science ®Google Scholar
• Nagi DK, McCormack LJ, Mohamed-Ali V, et al. Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes. Diabetes Care 1997;20:1304–1309
   PubMed Web of Science ®Google Scholar
• Santos A, Salguero ML, Gurrola C, et al. The epsilon4 allele of apolipoprotein E gene is a potential risk factor for the severity of macular edema in type 2 diabetic Mexican patients. Ophthalmic Genet 2002;23:13–19
   PubMedGoogle Scholar
• Maeda M, Yamamoto I, Fukuda M, et al. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients. J Diabetes Complications 2008;22:119–125
   PubMed Web of Science ®Google Scholar
• Syreeni A, El-Osta A, Forsblom C, et al. FinnDiane Study Group. Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes. Diabetes 2011;60:3073–3080
   PubMedGoogle Scholar
• Uthra S, Raman R, Mukesh BN, et al. Diabetic retinopathy and IGF-1 gene polymorphic cytosine-adenine repeats in a Southern Indian cohort. Ophthalmic Res 2007;39:294–299
   PubMedGoogle Scholar
• Uthra S, Raman R, Mukesh BN, et al. Protein kinase C beta (PRKCB1) and pigment epithelium derived factor (PEDF) gene polymorphisms and diabetic retinopathy in a south Indian cohort. Ophthalmic Genet 2010;31:18–23
   PubMed Web of Science ®Google Scholar
• Vinita K, Sripriya S, Prathiba K, et al. SNDREAMS Project. ICAM-1 K469E polymorphism is a genetic determinant for the clinical risk factors of T2D subjects with retinopathy in Indians: A population-based case-control study. BMJ Open 2012;2:pii: e001036
   Google Scholar
• Melzer D, Murray A, Hurst AJ, et al. Effects of the diabetes linked TCF7L2 polymorphism in a representative older population. BMC Med 2006;4:34
   PubMedGoogle Scholar
• Uthra S, Raman R, Mukesh BN, et al. Intron 4 VNTR of endothelial nitric oxide synthase (eNOS) gene and diabetic retinopathy in type 2 patients in southern India. Ophthalmic Genet 2007;28:77–81
   PubMed Web of Science ®Google Scholar
• Liu ZH, Guan TJ, Chen ZH, Li LS. Glucose transporter (GLUT1)allele (Xbal-) associated with nephropathy in non-insulin dependent diabetes mellitus. Kidney Int 1999;55:1843–1848
   PubMed Web of Science ®Google Scholar
• Grassi MA, Tikhomirov A, Ramalingam S, et al. Genome-wide meta-analysis for severe diabetic retinopathy. Hum Mol Genet 2011;20(12):2472–2481
   PubMed Web of Science ®Google Scholar
• Huang YC, Lin JM, Lin HJ, et al. Genome-wide association study of diabetic retinopathy in a Taiwanese population. Ophthalmology 2011;118(4):642–648
   PubMed Web of Science ®Google Scholar
• Schwartz SG, Brantley MA Jr. Pharmacogenetics and age-related macular degeneration. J Ophthalmol 2011;2011:252549
   PubMed Web of Science ®Google Scholar